BioConnect is on a Quest – for Rightful Identity. Why? To empower people to use credentials that are completely unique to them, such as their face, eyes, heartbeat or fingerprint, fundamentally changing how we access applications and processes. BioConnect’s core solutions – it’s identity management platform and applications are focused on enabling the easy adoption of current and future biometric technologies, delivering greater security, assurance and convenience in our every day lives today and tomorrow.
For over 65 years, Charles River employees have enjoyed rich careers working together to assist in the discovery, development and safe manufacture of new therapies for the patients who need them.
When you join Charles River, you become part of an international family that has had a significant impact on the health and well-being of our families, friends and colleagues across the globe. In the past few years alone we’ve helped our clients with the critical research required to develop new, approved treatments for cancer, weight loss, cystic fibrosis, leukemia, IBS, epilepsy, Cushing’s disease and other conditions.
Working at Charles River provides you with a chance to make a difference in the world. Whether your background is in life sciences, finance, quality, IT, sales or another area, your skills will play an important role in supporting the life-saving and valuable work we perform on behalf of our clients. In return, we’ll offer you opportunities to learn, grow and build a career that you can feel passionate about.
eSight Eyewear is a company with a simple but profound belief: that everyone deserves to see. eSight - electronic glasses that let the legally blind actually see - is a breakthrough for those living with low vision. eSight drastically enhances the vision of the visually impaired, without any surgery. It is a wearable, all-in-one assistive device that empowers the visually impaired with independence and choice.
The Guelph Vision Therapy Center provides vision therapy for patients with eye teaming issues. GVTC is the first clinic in Canada to integrate Occupational Therapy, Psychology, Speech and Language Pathology and Vision Therapy in a collaborative care effort. We aim to improve the lives through better coordination of eyes, brain and body. Our success is seeing patients go back to work and help children read and write at grade-level. A video on the background of the software we use can be seen at www.eyecarrot.com. For more information on GVTC’s therapy approach, please visit www.gvtc.ca or email us at at email@example.com.
Immunovaccine Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Immunovaccine’s DepoVax™ platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. Lead product candidate DPX-Survivac is currently being evaluated in several clinical trials in advanced ovarian cancer in combination with other innovative immunotherapy agents.
STEMCELL Technologies Inc. is a biotechnology company based in Vancouver that develops speciality cell culture media, cell isolation systems and accessory products for life science research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalogue of more than 2,000 cell biology research tools. STEMCELL is proud to be the largest Biotechnology employer in Canada.
Synaptive Medical is a newly-formed company based in Toronto, Canada, focused on developing medical equipment and applications for neurosurgical procedures. Together, these devices form a full and complete solution of visualization technologies for the operating room.
In the past 10 years, the core members of Synaptive Medical have founded and grown multiple successful medical start-ups into international markets. The company is growing rapidly and has a number of opportunities for motivated people to join the team and share in the challenges and rewards of developing technologies to improve patient care and outcomes in neurosurgery.
Therapure Biopharma Inc. is an integrated biopharmaceutical company focused on complex biological therapeutics and technologies that can provide new options for patient care. It is comprised of Therapure Biomanufacturing, the award-winning CDMO division and Therapure Innovations, the proprietary drug pipeline and platform technology research and development division. Therapure Biopharma Inc.’s 130,000 sq. ft. cGMP facility includes biomanufacturing, research and quality-control laboratories and is built to meet FDA (USA), HPFB (Canada), EMA (Europe) and MHRA (UK) standards.